Replies to post #78078 on Biotech Values

[oldberkeley]

Dew-

RE multiple Lovenox ANDA's:

I seem to remember reading that the FDA itself feels that there is a definite benefit to consumers if the FDA approves more than one ANDA: at least one of the generic drugs will reach the market more quickly.

IYO, any truth to this?